在FDA不良事件报告系统 (FAERS) 数据库中对蒙特卢卡斯特的真实数据分析
Hesen Huang1, Kaiqin Chen2, Yu Du1
1Department of Otolaryngology-Head and Neck Surgery, Xiang'an Hospital of Xiamen University, Xia Men, Fu Jian, 361102, China.
BMC pharmacology & toxicology
|July 2, 2025
概括
蒙特卢卡斯特 (MTK) 可能会引起意外的不良药物反应 (ADRs),如窒息和上腺抑制,其插入中没有列出. 需要进一步的研究来确认喘和鼻炎患者的这些潜在风险.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 临床药理学 临床药理学
背景情况:
- 蒙特卢卡斯特 (MTK) 是一种白血受体对抗剂,通常用于喘和鼻炎.
- 报道了与MTK相关的众多不良事件 (AEs),需要进一步调查.
研究的目的:
- 通过使用现实世界的数据,调查蒙特卢卡斯特 (MTK) 的潜在不良药物反应 (ADR).
- 从大型不良事件数据库中识别和分析与MTK相关的意想不到的AE.
主要方法:
- 使用了美国食品和药物管理局的不良事件报告系统 (FAERS) 数据库.
- 采用了不成比例分析,包括报告比率 (ROR) 的比率,比例报告比率 (PRR),贝叶斯式信念传播神经网络 (BCPNN) 和马鱼缩小器 (GPS).
主要成果:
- 分析了来自20340,254个FAERS病例 (2004-2023) 的86,732个MTK报告.
- 确定了与MTK相关的27个器官系统中的431个首选术语 (PT).
- 检测到意想不到的严重副作用,如窒息感,上腺抑制,突然视力丧失和内心纤维化.
结论:
- 结果表明MTK可能出现新的和意想不到的ADR信号,与一些临床观察一致.
- 强调需要进行前性临床研究来验证这些已识别的副作用.
- 通过大规模的真实世界数据,为研究药物不良事件提供了一个新的视角.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
495
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
495
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
476
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
476
01:26Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
398
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
398
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K